📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

RIPK3 as a potential therapeutic target for Gaucher's disease. (2014)

First Author: Vitner EB

Attributed to: Gene Therapy for Tay-Sachs and Sandhoff diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm.3449

PubMed Identifier: 24441827

Publication URI: http://europepmc.org/abstract/MED/24441827

Type: Journal Article/Review

Volume: 20

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956